AB INTL GROUP Announces Business Updates
August 20, 2024 08:51 ET
|
AB INTL Group Corp.
AB INTL GROUP Announces Business Updates
Shifting away from China for critical minerals would increase costs and delay the energy transition, warns Wood Mackenzie
August 15, 2024 00:15 ET
|
Wood Mackenzie
Shifting away from China for critical minerals would increase costs and delay the energy transition, warns Wood Mackenzie Replacing Chinese copper supply chains requires US$85 billion for new...
Panda Pair Makes Public Debut at the San Diego Zoo
August 14, 2024 12:20 ET
|
D S Simon
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- This month, the first pandas to enter the United States in 21 years will make their eagerly awaited public debut at the San Diego Zoo. Recently, Marco...
XPENG Announces Vehicle Delivery Results for July 2024
August 01, 2024 05:19 ET
|
XPeng Inc.
11,145 vehicles delivered in July 2024, marking the fifth consecutive month of both month-over-month and year-over-year growth63,173 vehicles delivered in the first seven months of 2024, a...
AB INTL GROUP Announced Fencing Film “THE ONE” Premiere for Screening on Cinemas in China
July 30, 2024 08:35 ET
|
AB INTL Group Corp.
AB INTL GROUP Announced Fencing Film “THE ONE” Premiere for Screening on Cinemas in China
LNG truck sales impacting Chinese road diesel demand
July 25, 2024 18:15 ET
|
Wood Mackenzie
China’s sales of heavy-duty trucks powered by liquefied natural gas (LNG) rose from below 10% to reach as much as 30% of the market in the latter months of 2023 resulting in the displacement of over...
25th Anniversary of Falun Gong Persecution
July 19, 2024 07:00 ET
|
Falun Dafa Association Canada
TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- July 20th marks 25 years since the Chinese Communist Party (CCP) launched its persecution and vilification campaign against people who practice the Falun...
萬聯行在香港獲得Targretin®️（Bexarotene）用於皮膚T細胞淋巴瘤的上市批准
July 16, 2024 02:54 ET
|
MAIN LIFE CORPORATION LIMITED
香港和澳門的獲批為Targretin®️首次在中國區域內上市Bexarotene為國際臨床慣例用於治療復發性皮膚T細胞淋巴瘤(CTCL)的標準藥物 香港, July 16, 2024 (GLOBE NEWSWIRE) --...
万联行获得Targretin®（Bexarotene 贝沙罗汀）在香港用于皮肤T细胞淋巴瘤的市场批准
July 16, 2024 02:54 ET
|
MAIN LIFE CORPORATION LIMITED
香港和澳门的批准标志着Targretin®首次在中国上市贝沙罗汀代表国际临床实践中对复发性皮肤T细胞淋巴瘤(CTCL)的标准治疗 香港, July 16, 2024 (GLOBE NEWSWIRE) -- 万联行有限公司（“Main Life”）今天宣布Targretin®（贝沙罗汀）胶囊在香港获得上市许可，用于治疗至少一次系统治疗无效的皮肤T细胞淋巴瘤 （Cutaneous T-cell...
Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
July 16, 2024 02:54 ET
|
MAIN LIFE CORPORATION LIMITED
Targretin® (Bexarotene) received Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma.